KAYTUS Unveils KSManage V2.0, Quadrupling Data Center O&M Efficiency
14.4.2025 09:02:00 CEST | Business Wire | Press Release
KAYTUS, a leading provider of end-to-end AI server and liquid cooling solutions, has announced the release of KSManage V2.0, its next-generation data center management platform. The upgraded platform offers broad compatibility with over 5,000 mainstream IT device models, enabling seamless integration across diverse environments. With one-click fully automated batch configuration, KSManage V2.0 boosts management efficiency by up to four times. Leveraging advanced AIOps capabilities, the platform achieves a fault diagnosis accuracy rate of over 98% and reduces energy consumption by 20%. These enhancements significantly optimize operations and maintenance (O&M) for scaled data centers, empowering sustainable and intelligent infrastructure management.
With the rapid advancement of cloud computing and AI applications, data centers have scaled at an unprecedented pace—from just over a hundred devices to tens of thousands. This explosive growth presents significant challenges for operations and maintenance (O&M), particularly in managing vast arrays of heterogeneous servers, storage systems, and network equipment. KSManage is purpose-built to address these complexities, delivering intelligent and efficient data center O&M. It tackles key pain points such as the difficulty of managing diverse hardware, low operational efficiency, and inconsistent infrastructure performance. By ensuring reliable, streamlined, and intelligent infrastructure operations, KSManage enables enterprises to focus entirely on driving their core business innovation.
Centralized Management, All-in-One Integrated Platform
A major challenge in scaled data centers is the management of heterogeneous devices across multiple vendors and models—each with its own management interfaces and protocols. While open-source tools offer basic functionality, their decentralized approach often leads to fragmented resource allocation and increased operational complexity. KSManage V2.0 addresses this with a unified, enterprise-grade platform designed to streamline O&M. It supports a wide range of IT devices from different vendors, offering compatibility with over 5,000 models of servers, storage systems, and network devices. Through standardized interfaces and protocols, KSManage V2.0 enables centralized, out-of-band management of heterogeneous infrastructure at scale—greatly simplifying operations while enhancing efficiency and control.
KSManage V2.0 delivers significant upgrades in data center monitoring and management, with enhanced capabilities across health monitoring, performance tracking, inspection management, and network testing tools. These improvements enable granular, component-level health monitoring, a comprehensive view of performance metrics, and customizable inspection workflows—offering a more precise and intelligent monitoring experience.
The platform supports both 2D and 3D global visualization, allowing users to monitor key resource metrics such as power consumption, temperature, and capacity in real time. This enhanced visibility empowers operators to proactively track infrastructure status and optimize management efficiency. In addition, KSManage V2.0 can generate customized visual analytics reports within minutes, simplifying data analysis and accelerating data-driven decision-making.
Fully Automated Batch Upgrades, Quadrupling Operational Efficiency
Server configuration low efficiency remains a major challenge in scaled data centers, where manual firmware upgrades are time-consuming, complex, and prone to human error. To address this, KSManage V2.0 introduces one-click automated batch upgrades, significantly simplifying workflows and boosting O&M efficiency. Complementing this capability, KAYTUS has launched the KSManage Repo, a centralized firmware repository that hosts the latest updates for KAYTUS servers. After registration and entry of device serial numbers (SNs), customers can connect to the official image repository to automatically detect and retrieve the most up-to-date firmware versions in real time. Leveraging both in-band and out-of-band communication channels, KAYTUS servers support full-stack firmware batch upgrades and automated configuration—including BMC, BIOS, CPLD, FRU, NICs, drives, and more—either online or via batch downloads. This automation ensures optimal device performance and delivers up to a 400% increase in maintenance efficiency.
AIOps for Enhanced Reliability and Energy Efficiency
Scaled data centers often face challenges related to infrastructure stability and excessive energy consumption. Manual monitoring lacks the responsiveness needed for real-time device analysis, while open-source management tools are frequently plagued by security risks, instability, and limited functionality—resulting in delayed fault detection, slow incident resolution, and potential business disruptions. Additionally, insufficient visibility into energy usage contributes to elevated power usage effectiveness (PUE). KSManage V2.0 addresses these issues through built-in AIOps capabilities, integrating intelligent operations throughout the entire lifecycle of fault prediction, alarm reporting, and diagnostics. The platform not only enhances fault response time and system stability but also provides real-time energy consumption tracking, including carbon emissions monitoring. This enables data centers to optimize energy efficiency and supports sustainable, eco-friendly operations aligned with green IT initiatives.
Intelligent Prediction and Rapid Diagnosis. KSManage V2.0 takes predictive maintenance and fault diagnosis to the next level with advanced AI-powered capabilities. It supports drive failure prediction up to 15 days in advance, while its memory failure prediction accuracy has improved by 30%. In the event of a fault, AI algorithms are leveraged for both performance and capacity prediction, enabling proactive and informed decision-making. Designed for scaled data centers, KSManage V2.0 can process real-time, billion-level O&M data within seconds, and respond to thousands of alarms in under five seconds. It employs an innovative ETF (Event-Trigger-Free) threshold-free alarm algorithm, achieving an impressive alarm accuracy rate of 95.26%. For diagnostics, KSManage V2.0 actively and passively monitors metric data and collects logs to quickly detect and accurately pinpoint faults—delivering a diagnostic accuracy rate exceeding 98%. These capabilities significantly improve operational resilience and reduce downtime across complex IT environments.
Comprehensive Energy Management for Sustainable Operations. KSManage V2.0 delivers robust energy consumption management across a wide range of data center infrastructure—including AI and general-purpose servers, storage systems, network equipment, cooling units, lighting, and power supply devices. Tailored to meet diverse business needs, KSManage V2.0 offers a variety of power consumption control strategies, enabling dynamic workload-based energy adjustments and visual tracking of carbon emissions. By intelligently managing workloads to maintain peak efficiency and avoiding no-load or overload conditions, the platform reduces overall energy consumption by 15% to 20%. In addition, KSManage V2.0 provides predictive energy analytics based on historical data trends, enabling data centers to proactively plan operational and energy strategies. This minimizes the risk of under- or over-supply of energy and supports sustainable, eco-friendly operations aligned with long-term carbon reduction goals.
KSManage has been successfully deployed across a wide range of industries, including cloud service providers (CSPs), finance, and telecommunications. In one notable case involving a leading e-commerce platform in Turkey, KSManage effectively addressed critical operational challenges such as inefficient firmware upgrades, error-prone configurations, and slow OS deployments. By automating the management of over 3,000 servers, KSManage reduced firmware upgrade time by 70%, increased configuration accuracy to 99.8%, and enabled the daily deployment of up to 500 servers. These improvements translated into an 80% boost in overall O&M efficiency and a 40% reduction in hardware failure rates.
About KAYTUS
KAYTUS is a leading provider of end-to-end AI and liquid cooling solutions, delivering a diverse range of innovative, open, and eco-friendly products for cloud, AI, edge computing, and other emerging applications. With a customer-centric approach, KAYTUS is agile and responsive to user needs through its adaptable business model. Discover more at KAYTUS.com and follow us on LinkedIn and X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414326624/en/
Contacts
Media contact
media@kaytus.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom